Company news
Renalytix PLC news in 2019
Renalytix PLC's news releases, calls and decks from 2019, newest first.
Medicare sets US national price for KidneyIntelX
December 3, 2019
Grant of Options
November 21, 2019
RenalytixAI attending City Event for Kidney Health
November 19, 2019
Partnership with CDPHP on KidneyIntelX
October 17, 2019
Board appointment
October 14, 2019
US CPT® reimbursement code effective
October 1, 2019
Update on non-executive director appointment
September 30, 2019
Final Results
September 3, 2019
Expansion of Chronic Kidney Disease Advisory Board
August 6, 2019
Thomas McLain Appointed as President and CCO
July 29, 2019
Result of Placing & Total Voting Rights
July 23, 2019
US Exec Order on Advancing American Kidney Health
July 12, 2019
Positive Interim Results for Validation Study
July 9, 2019
FractalDx Positive Results Published in JASN
July 8, 2019
US CPT® Code Granted for KidneyIntelX(TM)
July 1, 2019
Positive results from FractalDx study published
June 7, 2019
KidneyIntelX commercial scale production milestone
June 4, 2019
CLIA Certificate Number issued for Renalytix Lab
May 28, 2019
Expansion of FractalDx core investigator group
May 21, 2019
University Medical Center Groningen collaboration
May 7, 2019
FDA grants Breakthrough Device designation
May 2, 2019
Publication of confirmation study results
April 1, 2019
RenalytixAI Forms Core Investigator Group
March 22, 2019
Investor briefing
March 12, 2019
Appointment of Nomad and Joint Broker
February 14, 2019
Joint venture partnership agreement with AKESOgen
February 13, 2019
RenalytixAI Expands Leadership Team
February 6, 2019
Initiates Clinical Validation Study
January 23, 2019
Clarification re. lock-up restrictions
January 21, 2019
Exercise of Option for Exclusive License
January 2, 2019